Plain-English translation of NCT07596030 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a portable device called transcutaneous auricular vagus nerve stimulation (taVNS) to see if it can help reduce nerve pain and numbness caused by chemotherapy. The device delivers mild electrical stimulation through small electrodes placed on your outer ear, targeting a major nerve that may help reduce pain signals. This is a feasibility study, meaning researchers want to understand if people can use this device safely and easily at home.
Many cancer survivors experience lasting nerve pain and numbness in their hands and feet after chemotherapy, and this pain is difficult to treat with current medications. This study explores whether this new, portable, self-administered treatment could offer a gentle and accessible option for managing this common side effect of cancer treatment.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll either receive the treatment or be part of a comparison group. If you receive the treatment, you'll use a small handheld device on your ear once daily for 14 consecutive days at home, with each session lasting about 60 minutes. The study team will give you clear instructions, and they'll adjust the device's intensity to a comfortable level. You'll also complete some tests and measurements at the beginning and end of the two weeks.
AI-generated summary from trial data · Jul 19, 2026 · Not medical advice
United States